Trial Profile
A Phase 3, Randomized, Double-Blind, Multicenter Study of the Treatment of Antiretroviral-Naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz Versus Stavudine, Lamivudine, and Efavirenz
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Jun 2013
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary) ; Efavirenz; Lamivudine; Stavudine
- Indications HIV-1 infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors Gilead Sciences
- 16 Feb 2011 New trial record